Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Cytek Biosciences
CTKB
$636M
| $2.21M | ﹤0.01% |
+102,990
| New | +$2.42M |
|
2677
Root
ROOT
$772M
| $2.2M | ﹤0.01% |
23,209
+8,796
| +61% | +$1.09M |
|
2678
Atlassian
TEAM
$42.1B
| $2.2M | ﹤0.01% |
5,620
+924
| +20% | +$309K |
|
|
LITS
2679
Lite Strategy Inc
LITS
$30.5M
| $2.19M | ﹤0.01% |
39,722
+941
| +2% | +$51.8K |
|
|
MOMO
2680
Hello Group
MOMO
$850M
| $2.18M | ﹤0.01% |
206,293
+4,355
| +2% | +$54.6K |
|
2681
Aveanna Healthcare
AVAH
$2.46B
| $2.18M | ﹤0.01% |
271,856
+4,973
| +2% | +$48.2K |
|
2682
Lands' End
LE
$390M
| $2.18M | ﹤0.01% |
92,560
-16,220
| -15% | -$557K |
|
|
TCS
2683
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $2.17M | ﹤0.01% |
15,210
+4,515
| +42% | +$757K |
|
2684
Treace Medical Concepts
TMCI
$293M
| $2.17M | ﹤0.01% |
80,589
+1,832
| +2% | +$50.4K |
|
2685
Instil Bio
TIL
$49.3M
| $2.17M | ﹤0.01% |
6,059
+137
| +2% | +$51.1K |
|
2686
Alphatec Holdings
ATEC
$1.51B
| $2.17M | ﹤0.01% |
177,600
+9,848
| +6% | +$137K |
|
2687
Holley
HLLY
$362M
| $2.16M | ﹤0.01% |
+180,972
| New | +$2.03M |
|
|
FXLV
2688
DELISTED
F45 Training Holdings Inc.
FXLV
| $2.16M | ﹤0.01% |
+144,374
| New | +$2.12M |
|
2689
MasterCraft Boat Holdings
MCFT
$598M
| $2.15M | ﹤0.01% |
85,896
+23,205
| +37% | +$595K |
|
|
SGFY
2690
DELISTED
Signify Health, Inc.
SGFY
| $2.14M | ﹤0.01% |
119,805
-45,031
| -27% | -$1.16M |
|
|
LOVE
2691
LoveSac
LOVE
$258M
| $2.14M | ﹤0.01% |
32,329
+935
| +3% | +$58.6K |
|
|
MKFG
2692
DELISTED
Markforged Holding Corporation
MKFG
| $2.12M | ﹤0.01% |
+32,370
| New | +$2.88M |
|
2693
IDEAYA Biosciences
IDYA
$3.53B
| $2.12M | ﹤0.01% |
83,185
+17,549
| +27% | +$410K |
|
2694
EverCommerce
EVCM
$1.79B
| $2.12M | ﹤0.01% |
+128,376
| New | +$2.36M |
|
2695
Aligos Therapeutics
ALGS
$42.3M
| $2.1M | ﹤0.01% |
5,413
+1,851
| +52% | +$732K |
|
|
MLNK
2696
DELISTED
MeridianLink
MLNK
| $2.08M | ﹤0.01% |
+93,137
| New | +$2.3M |
|
|
CUTR
2697
DELISTED
Cutera, Inc.
CUTR
| $2.06M | ﹤0.01% |
44,254
+26
| +0.1% | +$1.28K |
|
2698
Duluth Holdings
DLTH
$151M
| $2.06M | ﹤0.01% |
151,068
+63,793
| +73% | +$1.02M |
|
|
IHC
2699
DELISTED
Independence Holding Company
IHC
| $2.06M | ﹤0.01% |
41,527
-8,372
| -17% | -$385K |
|
2700
Accuray
ARAY
$32.9M
| $2.06M | ﹤0.01% |
520,084
-406,584
| -44% | -$1.61M |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.